Mericitabine Uses, Dosage, Side Effects and more
Mericitabine has been investigated for the treatment of Hepatitis C, Chronic.
Mericitabine is a polymerase inhibitor being developed for the treatment of chronic hepatitis C. Mericitabine is a prodrug of PSI-6130, which demonstrated excellent potency in preclinical studies. PSI-6130 is a pyrimidine nucleoside analog inhibitor of HCV RNA polymerase, an enzyme that is necessary for hepatitis C viral replication.
| Trade Name | Mericitabine |
| Generic | Mericitabine |
| Mericitabine Other Names | Mericitabine |
| Type | |
| Formula | C18H26FN3O6 |
| Weight | Average: 399.419 Monoisotopic: 399.180563732 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
